Navigation Links
Statins fail to reduce mortality rate in sepsis patients with ARDS
Date:5/18/2014

Despite previously-reported observational and basic science evidence suggesting the use of statins may improve outcomes in patients with sepsis and acute respiratory distress syndrome (ARDS), a double-blinded clinical trial of rosuvastatin in those patients was futile, and the study was halted.

The findings are published in the May 18, 2014 New England Journal of Medicine, along with accompanying editorials evaluating the research's goals and outcomes. The primary investigator and lead author of the study is Jonathon D. Truwit, M.D., professor of medicine and enterprise chief medical officer and senior administrative dean at Froedtert & the Medical College of Wisconsin.

Despite improvements in supportive care for ARDS, the mortality rate remains high, one in four patients die. Sepsis is the major reason patients develop ARDS. Statins have been shown to reduce inflammation and prevent ARDS in basic science studies, and have also been reported in observational studies to improve outcomes in patients with sepsis and ARDS.

In this study, patients received either the rosuvastatin or a placebo, and the study was double-blinded. After 745 of the proposed 1000 patients had been enrolled in the multi-center trial, the study was halted because there was no significant difference between the study groups. Further, the rosuvastatin therapy may have contributed to hepatic and renal organ dysfunction.

"While this therapy did not lead to better outcomes, it is important that we evaluate possible therapies for conditions such as ARDS because it adds to our knowledge about this condition, which has a high mortality rate for patients. The information gathered in this study will guide further basic and clinical research to ultimately improve our care for critically ill patients," said Dr. Truwit.


'/>"/>

Contact: Maureen Mack
mmack@mcw.edu
414-955-4744
Medical College of Wisconsin
Source:Eurekalert

Page: 1

Related medicine news :

1. Are statins good for your love life?
2. Statins could ease coughing in lung disease patients, study finds
3. High potency statins linked to better outcome following a heart attack
4. Could statins be used to fight a deadly viral infection?
5. As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Publication of New Study with Possible Explanation for Link between Statins and Diabetes
6. Cleveland Clinic research: Most statin-intolerant patients can eventually tolerate statins
7. High dose statins prevent dementia
8. Statins reduce CV events in CAD patients with very low LDL-C
9. Statins prevent cataracts
10. Specialized treatment helps cholesterol patients who suffer side effects from statins
11. Could Statins Raise Diabetes Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2018)... ... October 13, 2018 , ... ... Sports, Fitness & Nutrition, has announced LaRhonda Burley as its new Vice President ... chartered in 2010 to support and strengthen the mission of the President's Council ...
(Date:10/11/2018)... ... 11, 2018 , ... The Danisco Foundation today has awarded ... fields recognized by DuPont Nutrition & Health for scientific excellence and a remarkable ... food, nutrition and health. , This year’s medalists are: , ? DuPont Nutrition ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... quite vulnerable to manipulation,” warns former U.S. Department of Homeland Security deputy assistant ... Vulnerable and How We Can Stop it. , Pointing to the ability of ...
(Date:10/7/2018)... ... October 07, 2018 , ... Guruji Mahendra Trivedi ... affecting humanity at practical and spiritual levels. Founder of the Trivedi Effect®, Guruji ... ‘Special Prayers’, inspired by Navratri, is a mystical time when Divine Energy is ...
(Date:10/6/2018)... ... October 06, 2018 , ... The iaedp™ ... who treat the full spectrum of eating disorders (ED), today welcomed KellerLife Center ... “As with each of our Presidents Council members, it is an honor for ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... Canada (PRWEB) , ... October 16, 2018 , ... ... innovative companies involved in the development and marketing of algae-based omega-3 products, Ben ... the 2018 Algae Biomass Summit in Houston, Texas on October 15. The title ...
(Date:10/16/2018)... ... October 16, 2018 , ... The ... international multidisciplinary group of healthcare treatment providers who treat the full spectrum of ... in a live, two-day, 12-hour track at Symposium 2019. The courses are ...
(Date:10/13/2018)... ... ... As news hits that the annual growth rate of the global pet ... million in 2017 to $7170 million in 2023, technology specialist Aquarium Software says technology ... news comes hot on the heels of an announcement showing that the number of ...
Breaking Medicine Technology: